These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10295362)

  • 1. Clinical use of in vivo magnetic resonance spectroscopy (MRS).
    Health Technol; 1987; 1(1):38-9, 44. PubMed ID: 10295362
    [No Abstract]   [Full Text] [Related]  

  • 2. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts.
    Kreis R
    NMR Biomed; 2004 Oct; 17(6):361-81. PubMed ID: 15468083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care technology assessment.
    Steinberg EP
    Med Sect Proc; 1986; ():53-63. PubMed ID: 3601938
    [No Abstract]   [Full Text] [Related]  

  • 4. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions.
    Lai PH; Hsu SS; Ding SW; Ko CW; Fu JH; Weng MJ; Yeh LR; Wu MT; Liang HL; Chen CK; Pan HB
    Surg Neurol; 2007; 68 Suppl 1():S25-36. PubMed ID: 17963918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technology assessment in biomedical research: magnetic resonance imaging as a case in point.
    Burton BT; Heyse SP
    J Nucl Med Allied Sci; 1985; 29(4):331-5. PubMed ID: 3835248
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vivo magnetic resonance spectroscopy].
    Bakken IJ; Skjetne T; Gribbestad IS; Kvistad KA
    Tidsskr Nor Laegeforen; 2002 May; 122(14):1365-8. PubMed ID: 12098905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR study will lead to Medicare coverage rules.
    Beck E
    HPN Hosp Purch News; 1984 Jul; 8(7):40-1. PubMed ID: 10299543
    [No Abstract]   [Full Text] [Related]  

  • 8. MRS quality assessment in a multicentre study on MRS-based classification of brain tumours.
    van der Graaf M; Julià-Sapé M; Howe FA; Ziegler A; Majós C; Moreno-Torres A; Rijpkema M; Acosta D; Opstad KS; van der Meulen YM; Arús C; Heerschap A
    NMR Biomed; 2008 Feb; 21(2):148-58. PubMed ID: 17458918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo HR-MAS MRS of human meningiomas: a comparison with in vivo 1H MR spectra.
    Tugnoli V; Schenetti L; Mucci A; Parenti F; Cagnoli R; Righi V; Trinchero A; Nocetti L; Toraci C; Mavilla L; Trentini G; Zunarelli E; Tosi MR
    Int J Mol Med; 2006 Nov; 18(5):859-69. PubMed ID: 17016616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR issues for 1985 and beyond. Guideline report.
    diMonda R
    Hosp Technol Ser; 1985; 4(3-4):1-235. PubMed ID: 10269780
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved devices can enhance hospitals' images.
    Rollo FD
    Hospitals; 1983 Nov; 57(21):61-2, 65-6, 68. PubMed ID: 6618476
    [No Abstract]   [Full Text] [Related]  

  • 12. Technology '83: looking at NMR and other developments as the DRG system approaches.
    Rev Fed Am Hosp; 1983; 16(4):20-34, 39-48. PubMed ID: 10310060
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing the impact of DRG-PPS on capital investments.
    Caterinicchio RP
    Adm Radiol; 1987 Mar; 6(3):29-30, 32. PubMed ID: 10312057
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines for using proton MR spectroscopy in multicenter clinical MS studies.
    De Stefano N; Filippi M; Miller D; Pouwels PJ; Rovira A; Gass A; Enzinger C; Matthews PM; Arnold DL
    Neurology; 2007 Nov; 69(20):1942-52. PubMed ID: 17998486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo phenotyping of the ob/ob mouse by magnetic resonance imaging and 1H-magnetic resonance spectroscopy.
    Calderan L; Marzola P; Nicolato E; Fabene PF; Milanese C; Bernardi P; Giordano A; Cinti S; Sbarbati A
    Obesity (Silver Spring); 2006 Mar; 14(3):405-14. PubMed ID: 16648611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectroscopic magnetic resonance imaging of the brain: voxel localisation and tissue segmentation in the follow up of brain tumour.
    Poloni G; Bastianello S; Vultaggio A; Pozzi S; Maccabelli G; Germani G; Chiarati P; Pichiecchio A
    Funct Neurol; 2008; 23(4):207-13. PubMed ID: 19331784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of in vivo 1H magnetic resonance spectroscopy in the liver: a review.
    Fischbach F; Bruhn H
    Liver Int; 2008 Mar; 28(3):297-307. PubMed ID: 18290772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
    Tse GM; Yeung DK; King AD; Cheung HS; Yang WT
    Breast Cancer Res Treat; 2007 Sep; 104(3):249-55. PubMed ID: 17051424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease.
    Henchcliffe C; Shungu DC; Mao X; Huang C; Nirenberg MJ; Jenkins BG; Beal MF
    Ann N Y Acad Sci; 2008 Dec; 1147():206-20. PubMed ID: 19076443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it now time to acquire magnetic resonance imaging? Issues and concerns.
    J Health Care Technol; 1985; 2(1):23-50. PubMed ID: 10300489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.